GBM AGILE trial knowledge reveals clinically significant enchancment in a prespecified secondary evaluation for general survival in paxalisib-treated, newly identified unmethylated sufferers with...
Evgen Pharma (GB:TCF) has launched an replace.
TheraCryf plc has introduced that analysis on their drug SFX-01 as a radiosensitiser in Rhabdomyosarcoma, a standard...